Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-05-18 @ 1:12 PM
Study NCT ID:
NCT07245069
Status:
RECRUITING
Last Update Posted:
2025-11-24
First Post:
2025-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients
Sponsor:
University Medical Centre Ljubljana
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
0120-383/2024-2711-3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None